Unknown

Dataset Information

Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant.


ABSTRACT:

SUBMITTER: Xia S 

PROVIDER: S-EPMC8793821 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sorry, this publication's infomation has not been loaded in the Indexer, please go directly to PUBMED or Altmetric.

Similar Datasets